In gliomas 35 and cervical 36, pancreatic 37, and colorectal cancer 38, the overexpression of PHGDH is associated with advanced TNM stage, large tumor, higher tumor grade, and shorter overall survival time, respectively. Here, PHGDH is linked to neoplasm.